Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health is expanding its COVID-19 testing services to include rapid-result tests at nearly 1,000 locations by year-end. They have already administered over 5 million tests since March and currently operate 4,000 drive-thru sites across 33 states and Washington, D.C. Rapid-result diagnostics will allow for quicker identification of COVID-19, helping to reduce community spread. Patients eligible for the no-cost tests must register in advance. Nearly 100 sites are set to operate this week, with testing available for ages 12 and up. More details can be found on CVS's website.
CVS Pharmacy has launched QuickRenew, an online tool for at-home contact lens prescription renewals, leveraging technology from Premium Vision. This service is aimed at improving healthcare accessibility, particularly amid the pandemic, allowing customers in 32 states to renew prescriptions quickly and order lenses online. Customers must be 18-55 and meet specific eye health criteria. Additionally, CVS Optical has introduced an online glasses store with competitive pricing, starting at $79, enhancing their digital offering and customer experience.
CVS Health will host a conference call on November 6, 2020, at 8:00 a.m. ET to discuss its third-quarter 2020 financial results. Interested parties can access the live audio webcast on the CVS Health website. The call will be archived for one year post-event. CVS Health focuses on becoming the most consumer-centric health company, with nearly 10,000 local touchpoints, and aims to transform health through innovative programs and HealthHUB® locations, creating simpler, affordable healthcare experiences.
On October 21, 2020, CVS Health announced new initiatives aimed at preventing opioid misuse amid the pandemic. The programs include a digital curriculum, "Dose of Knowledge," developed in collaboration with Discovery Education, to educate students on drug misuse. CVS Health has committed nearly $3 million in grants to local organizations for addiction treatment and prevention. Additionally, CVS is enhancing access to naloxone, offering free delivery of the overdose-reversal drug in 30 states. CVS will also participate in the National Prescription Take Back Day to promote safe medication disposal.
CVS Health (NYSE: CVS) announced plans to hire 15,000 new employees, focusing on pharmacy technicians, to address the anticipated increase in COVID-19 and flu cases this fall and winter. Over 10,000 positions will be filled at CVS Pharmacy locations, with many being temporary roles that could become permanent. This recruitment drive is part of a larger effort where CVS aims to hire 50,000 employees in response to the pandemic. Job seekers can apply online for various positions, including pharmacists and customer service representatives.
CVS Health (NYSE: CVS) announced its plan to provide COVID-19 vaccinations to long-term care facilities nationwide once the vaccine is available. With experience from administering over nine million flu shots and five million COVID tests, CVS aims to help protect vulnerable elderly populations. The company operates 3,700 drive-thru testing sites and plans to administer approximately four million COVID-19 tests monthly. CEO Larry Merlo emphasized CVS's role in combating COVID-19, showcasing its capabilities to address community health needs effectively.
CVS Health Corporation has announced a quarterly dividend of $0.50 per share, payable on November 2, 2020, to shareholders on record by October 22, 2020. This decision by the board of directors underscores the company's commitment to returning value to its investors. CVS is focused on evolving into a consumer-centric health company, leveraging nearly 10,000 local touchpoints and innovative programs designed to enhance healthcare accessibility and affordability.
Aetna, a CVS Health company, unveiled its 2021 Medicare offerings, focusing on enhanced integration with CVS and new Medicare Advantage plans. Key highlights include the addition of HMO and Dual Eligible Special Needs Plans in new states, as well as Aetna Medicare Eagle plans tailored for Veterans. Aetna also introduced the lowest premium standalone prescription drug plan in the U.S. with an average premium of $7.15. With nearly 9.2 million Medicare members, Aetna aims to provide affordable and convenient care to a broader beneficiary population.
On September 22, 2020, U.S. News & World Report, alongside the Aetna Foundation, unveiled the third annual Healthiest Communities rankings, with new tools tracking COVID-19 data and its effects on community health. The initiative, part of CVS Health’s $100 million commitment to community wellness, emphasizes the disparities worsened by the pandemic. Top-ranked communities include Los Alamos County, New Mexico, and Douglas County, Colorado. The rankings evaluate 3,000 communities based on 84 health metrics across multiple categories.
CVS Health (NYSE: CVS) announced plans to establish over 2,000 new COVID-19 drive-thru test sites, aiming to exceed 4,000 locations by mid-October. This expansion solidifies CVS's position as the operator of the largest number of independent COVID-19 test sites in the U.S., facilitating testing in 33 states and Washington, DC. The tests are self-swabbed at no cost to patients meeting CDC criteria and results are typically available within 2-3 days. CVS emphasizes its commitment to community health and access to essential services during the pandemic.